Amarin Corp Plcuk
- Last sale
- Nov 12, 2026 · -0.43%
- Market cap
- $4.91B
- 421.63M shares
- Filings
- 1,015
Q3 2026−6.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2020derivedN/M FY20 yoy
Q3 2026N/M FY25 yoy
Q3 2026+11.3% FY25 yoy
- $4.91B
- —
- 27.9×
- 11.0×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $213,646,000 | reported | |
| FY 2024 | 2024-12-31 | $228,614,000 | reported | |
| FY 2023 | 2023-12-31 | $306,911,000 | reported | |
| FY 2022 | 2022-12-31 | $369,193,000 | reported | |
| FY 2021 | 2021-12-31 | $583,187,000 | reported | |
| FY 2020 | 2020-12-31 | $614,060,000 | reported | |
| FY 2019 | 2019-12-31 | $429,755,000 | reported | |
| FY 2018 | 2018-12-31 | $229,214,000 | reported | |
| FY 2017 | 2017-12-31 | $181,104,000 | reported | |
| FY 2016 | 2016-12-31 | $130,084,000 | reported | |
| FY 2015 | 2015-12-31 | $81,756,000 | reported | |
| FY 2014 | 2014-12-31 | $54,202,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2015 | — | $194.00K | $194.00K | — | 183.40M sh | +5.0% | — |
Segments
Products
LineFY2025ShareChange
Product Revenue, Net$182.75M86%−10.7%
Licensing and Royalty Revenue$30.89M14%+28.6%
Total$213.65M
Pharmaceutical preparations
Amarin Corp Plcuk is the 84th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
KROSKeros Therapeutics, Inc.$244.1M6,775.0%35.7%$197.2MAKBAAkebia Therapeutics, Inc.$236.2M47.5%2.3%$138.5MANABAnaptysbio, Inc$234.6M157.0%5.6%$1.4BPBYIPuma Biotechnology, Inc.$228.4M0.9%13.6%$418.0MIDYAIDEAYA Biosciences, Inc.$218.7M3,024.4%52.0%$3.0BVNDAVanda Pharmaceuticals Inc.$216.1M8.7%102.0%$238.9M
AMRNAmarin Corp Plcuk (this company)$213.6M6.5%18.2%$4.9B
RYTMRhythm Pharmaceuticals, Inc.$189.8M45.8%103.6%$7.6BMRVIMaravai Lifesciences Holdings, Inc.$185.7M28.3%70.4%$2.0BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Amarin Corp Plcuk · CIK 897448 · Engraved from SEC EDGAR